Search results
Nuclear medicine booms in central Indiana - Indianapolis Business Journal
Indianapolis Business Journal· 12 hours agoInside a large manufacturing building on the northwest side, officials at Cardinal Health are busy...
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
GuruFocus.com via Yahoo Finance· 4 hours agoOn May 16, 2024, Amir Weiss, the Chief Accounting Officer of Teva Pharmaceutical Industries Ltd...
Cytisinicline shows promise in vaping cessation trial By Investing.com
Investing.com· 47 minutes agoAchieve Life Sciences, Inc. (NASDAQ: NASDAQ:ACHV), a pharmaceutical company focused on the...
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Expected to Earn Q1 2025 Earnings of ($1.16) Per Share
ETF DAILY NEWS· 13 hours agoInovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Inovio Pharmaceuticals
Market Whales and Their Recent Bets on ALNY Options - Alnylam Pharmaceuticals (NASDAQ:ALNY)
Benzinga· 1 day agoRNAi is a naturally occurring biological pathway...type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines ...
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Zacks via Yahoo Finance· 4 hours agoApart from the above areas, Biogen and Ionis are developing numerous investigational medicines to...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy | The...
The Motley Fool· 5 days agoVertex Pharmaceuticals is making steady progress toward earning approval for a new CF medicine....
ISPE International Board of Directors Announces the Retirement of Thomas B. Hartman, President and...
PRWeb· 7 hours ago/PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) International Board of Directors has announced the retirement of Thomas B....
Leonard S. Schleifer Sells 25,000 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock
ETF DAILY NEWS· 14 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 25,000 shares of Regeneron Pharmaceuticals stock in a transaction ...
French health groups put forward proposals to limit the damage of worsening drug shortages
Euronews via Yahoo News· 1 day agoPharmaceutical companies’ lack of transparency leads to rising drug prices and less control over...